⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4366974 | 0.72 | — | — | |
| SCHEMBL2391487 | 0.72 | — | — | |
| SCHEMBL1725771 | 0.72 | — | — | |
| SCHEMBL19223384 | 0.72 | — | — | |
| SCHEMBL126880 | 0.72 | — | — | |
| SCHEMBL23037778 | 0.67 | — | — | |
| Ammonia Solution, Strong SCHEMBL7515887 | 0.67 | — | — | |
| Ammonia Solution, Strong SCHEMBL7515880 | 0.67 | — | — | |
| SCHEMBL9116309 | 0.67 | — | — | |
| SCHEMBL25173724 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4327882-A2 | ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023077083-A1 | ENPP1 INHIBITORS AS INHIBITORS OF METASTASIS | ANGARUS THERAPEUTICS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| US-6498241-B1 | 2-deoxy-isoguanosines isosteric analogues and isoguanosine derivatives as well as their synthesis | ROCHE DIAGNOSTICS GMBH (DE) | 2002-12-24 | — | — | US | disclosed |
| US-6147199-A | 2-deoxy-isoguanosines isoteric analogues and isoguanosine containing oligonucleotides | BOEHRINGER MANNHEIM (DE) | 2000-11-14 | — | — | US | disclosed |